Albendazole Single Dose for Adults: Timeline, Cure Rates, Safety

Albendazole 400 mg as a single oral dose is the standard adult treatment for intestinal roundworm, hookworm, and pinworm infections, and it works by starving the parasite of glucose rather than killing it outright. One dose produces cure rates of roughly 85 to 95 percent for roundworm and pinworm and about 60 to 80 percent for hookworm. Most adults need no repeat dose and no fasting, though the drug is absorbed poorly unless taken with a fatty meal for tissue-stage infections.

How a single 400 mg dose actually works

Albendazole belongs to the benzimidazole class. Its job is not to poison the worm directly. It binds tubulin, the protein building block of the parasite's microtubules, and blocks their assembly at a binding affinity roughly 100 times higher for nematode tubulin than for human tubulin. That selectivity gap is why one dose is tolerable to the human host while being lethal to the worm.

The block on microtubule assembly shuts down glucose uptake in the parasite's intestinal cells. The worm cannot absorb sugar, exhausts its glycogen reserves within hours, and dies or is expelled. This is a starvation mechanism, not a neurotoxin mechanism, which distinguishes albendazole from drugs like ivermectin.

Albendazole is poorly water-soluble and poorly absorbed from the gut. When taken without food, only about 1 to 5 percent reaches the bloodstream, which is ideal for a gut-lumen worm because the drug stays where the parasite lives. When a fatty meal is added, plasma levels rise several-fold, and that absorption matters for tissue infections like neurocysticercosis. The single-dose gut-worm strategy exploits the drug's poor absorption as a feature, not a flaw.

In plain terms: the tablet mostly stays in your intestine, which is exactly where the worms are.

Quantified cure rates by parasite species

Efficacy is species-specific, and a single dose does not perform equally across all intestinal worms. The following figures reflect pooled trial data and World Health Organization guidance on soil-transmitted helminths.

The whipworm figure is the non-obvious one. Trichuris lives embedded in the cecal mucosa and is harder to reach with a single luminal dose, so a 400 mg one-shot cure rate can fall below 50 percent in some trials. For whipworm, a 3-day course of 400 mg daily is the more reliable choice, and this is a professional caveat that many one-dose explainers omit.

For pinworm, the single dose kills adult worms but not eggs. Reinfection from eggs in the environment is common, so a second dose at two weeks is the standard to break the cycle. The two-week interval matches the egg-to-adult maturation time.

Timeline: what happens after you swallow the tablet

The drug's time course inside the body is short, but the worm die-off and symptom resolution follow a longer arc. The table below reconciles the pharmacokinetic timeline with the clinical timeline.

Plasma half-life of albendazole sulfoxide, the active metabolite, is about 8 to 12 hours. The drug is essentially cleared within 2 to 3 days, yet worm expulsion can continue for up to a week as dead worms work through the gut. This mismatch between drug clearance and clinical effect surprises patients who expect immediate relief.

Who needs a different dose or schedule

The single 400 mg adult dose assumes normal liver function and a non-pregnant adult. Several groups need adjustment.

Pregnancy is the most important caveat. Albendazole is generally avoided in the first trimester because of animal data suggesting teratogenicity, though human data have not confirmed this risk. The World Health Organization permits single-dose treatment in the second and third trimesters for soil-transmitted helminths where infection burden is high. Pregnant adults should not self-treat.

Liver function matters because albendazole is metabolized hepatically. Adults with significant hepatic impairment may need monitoring, and prolonged courses for tissue infections require liver enzyme checks.

Drug interactions are real. Cimetidine raises albendazole plasma levels by inhibiting its metabolism, and dexamethasone also increases levels. Conversely, the antiepileptic drugs phenytoin and carbamazepine lower albendazole levels and can reduce efficacy. Albendazole is a moderate CYP3A4 inducer and can lower levels of oral contraceptives, so backup contraception is advised during treatment.

Weight-based dosing applies mainly to children. Adults of normal weight use the flat 400 mg dose regardless of body mass, because the gut-lumen effect does not scale meaningfully with weight for intestinal worms.

Common misconceptions corrected

The most persistent misconception is that a single dose kills every worm species equally. It does not. The 40 to 70 percent whipworm cure rate versus the 85 to 95 percent roundworm rate is a real gap that changes treatment choice.

A second misconception is that food should be avoided. For intestinal worms, taking the tablet with or without food makes little clinical difference because the drug acts in the lumen. For tissue infections like cysticercosis or hydatid disease, a fatty meal is actively recommended to raise absorption. The advice flips depending on indication.

A third misconception concerns alcohol and fasting rules borrowed from other antiparasitics. Albendazole does not require fasting, and there is no strict alcohol prohibition, though heavy drinking stresses the liver that metabolizes the drug.

Finally, many assume one dose prevents reinfection. It does not. Albendazole treats the current infection only. In high-transmission settings, reinfection rates can reach 30 to 50 percent within 6 to 12 months, which is why mass deworming programs repeat treatment annually or twice yearly.

What to actually do

Take the 400 mg tablet as a single dose, swallowed whole with water. You do not need to fast, and you do not need to take it at a specific time of day.

For pinworm, plan the second dose at exactly two weeks. Wash bedding and underwear in hot water on the same day to reduce egg load in the environment.

For suspected hookworm or whipworm, ask about a 3-day course rather than a single dose. A single dose under-treats these species, and the marginal cost of two extra tablets is small.

If you are pregnant, breastfeeding, or on epilepsy medication, do not self-treat. Speak to a clinician about timing and alternatives.

Safety, side effects, and red-flag warnings

Albendazole single-dose therapy is generally well tolerated. The most common side effects are mild and transient: abdominal discomfort in roughly 1 to 5 percent of adults, nausea, headache, and dizziness. Most resolve within a day.

Serious adverse events with a single gut-worm dose are rare. However, certain situations require urgent medical attention.

• Severe abdominal pain, rigid abdomen, or fever after treatment, which can signal intestinal obstruction from a heavy worm load dying at once.
• New rash, facial swelling, or difficulty breathing, which may indicate a hypersensitivity reaction.
• Yellowing of the eyes or skin, dark urine, or persistent vomiting, which can indicate liver injury.
• Visual changes or severe headache during treatment for tissue infections, which can reflect inflammation around dying cysts.
• Pregnancy discovered after dosing, which warrants a clinician conversation rather than panic.

The obstruction warning is the counterintuitive edge case. In a very heavy roundworm infection, a single dose can kill many worms simultaneously, and the dead mass can theoretically contribute to blockage. This is uncommon but documented, and it is why heavy infections in frail adults are sometimes treated under supervision.

A corrected figure worth stating: the widely repeated claim that albendazole is "completely safe in pregnancy" is not supported. Animal studies show teratogenic signals at high doses, and human data remain limited. The risk is likely low for a single dose, but the honest position is caution in the first trimester, not certainty of safety.

Limitations and what the evidence does not show

The evidence base for single-dose albendazole is strong for Ascaris and pinworm and weaker for hookworm and whipworm. Cure rates vary by region because of parasite strain differences and because some areas have reduced benzimidazole efficacy. In parts of sub-Saharan Africa, hookworm cure rates with a single dose have fallen below 60 percent, a signal of possible emerging tolerance.

Albendazole does not treat protozoal infections like Giardia or Cryptosporidium. It is a nematode drug, not a broad antiparasitic. Adults with diarrhea and a suspected protozoan cause need a different agent, such as metronidazole or nitazoxanide.

Finally, a single dose is not a substitute for diagnosis. Stool testing confirms which parasite is present and whether a repeat or longer course is needed. Treating blindly works often enough to be common in endemic areas, but in a high-income setting with access to testing, confirmation changes management in a meaningful share of cases.

For adults with uncomplicated intestinal roundworm or pinworm, one 400 mg dose is a well-established, low-cost, and highly effective option. For hookworm and whipworm, the same dose is a starting point, not a guaranteed cure, and the species matters more than the tablet.